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Although much effort has been directed at dissecting the mechanisms of central tolerance, the role of thymic stromal
cells remains elusive. In order to further characterize this event, we developed a mouse model restricting LacZ to
thymic stromal cotransporter (TSCOT)-expressing thymic stromal cells (TDLacZ). The thymus of this mouse contains
approximately 4,300 TSCOT
þ cells, each expressing several thousand molecules of the LacZ antigen. TSCOT
þ cells
express the cortical marker CDR1, CD40, CD80, CD54, and major histocompatibility complex class II (MHCII). When
examining endogenous responses directed against LacZ, we observed significant tolerance. This was evidenced in a
diverse T cell repertoire as measured by both a CD4 T cell proliferation assay and an antigen-specific antibody isotype
analysis. This tolerance process was at least partially independent of Autoimmune Regulatory Element gene expression.
When TDLacZ mice were crossed to a novel CD4 T cell receptor (TCR) transgenic reactive against LacZ (BgII), there was a
complete deletion of double-positive thymocytes. Fetal thymic reaggregate culture of CD45- and UEA-depleted thymic
stromal cells from TDLacZ and sorted TCR-bearing thymocytes excluded the possibility of cross presentation by thymic
dendritic cells and medullary epithelial cells for the deletion. Overall, these results demonstrate that the introduction
of a neoantigen into TSCOT-expressing cells can efficiently establish complete tolerance and suggest a possible
application for the deletion of antigen-specific T cells by antigen introduction into TSCOT
þ cells.
Citation: Ahn S, Lee G, Yang SJ, Lee D, Lee S, et al. (2008) TSCOT
þ thymic epithelial cell-mediated sensitive CD4 tolerance by direct presentation. PLoS Biol 6(8): e191. doi:10.
1371/journal.pbio.0060191
Introduction
T cell tolerance is established mainly in the thymus where
the T cell population develops and learns by a process called
negative selection to avoid harmful reactivity against self-
antigens expressed in that thymus (reviewed in [1,2]). In the
periphery, organ-speciﬁc tolerance can be established by
various other mechanisms, including anergy [3], ignorance
[4], and regulatory T cells [5]. Furthermore, antigen-present-
ing cells (APC) lacking costimulatory molecules in peripheral
tissues initiate abortive immune responses [6].
The thymic microenvironment is organized and equipped
to achieve efﬁcient self-tolerance by providing stimulatory
signals to developing self-reactive thymocytes. For a diverse T
cell repertoire, this negative selection process occurs primar-
ily in the thymic medullary compartment (reviewed in [7,8]).
The major player among the hematopoietic cells is the
dendritic cell (DC), which possesses a highly efﬁcient antigen
presentation capability. In addition, it is widely accepted that
thymic medullary epithelial cells (mTEC) that express low
levels of tissue-speciﬁc peripheral antigens in a promiscuous/
ectopic fashion [9,10] can also initiate clonal deletion.
Discovery of the AIRE gene and its expression in mTEC has
led to an understanding of its critical regulatory role in the
removal of autoreactive T cells, particularly against tissue-
speciﬁc antigens expressed in the endocrine system (reviewed
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PLoS BIOLOGYin [11,12]). However, AIRE is also expressed in non-mTEC,
including thymic DC [13,14] and in cortical thymic epithelial
cells (cTEC) from Rag-2–deﬁcient thymus [15]. Furthermore,
the cross-presentation pathway can participate in the CD4
and CD8 tolerance for the membrane-bound antigens [16].
Therefore, the natures of cell types responsible for the
tolerance induction still remain unsettled.
The role of cortical epithelium in tolerance induction has
been controversial (reviewed in [17–20]). Several experiments
using thymus transplantation have clearly indicated that
thymic epithelium exhibits toleragenic function [21–24]. In
contrast, experiments using transgenic mice with targeting of
major histocompatibility complex class II (MHCII) [25] or
MHCI [26] molecules to the thymic cortical compartment
(and the skin) using a fortuitous keratin 14 promoter led to
the conclusion that cTEC are not capable of inducing
tolerance. Such results have given rise to the idea that the
thymic microenvironment is compartmentalized, with pos-
itive selection taking place in the cortex and negative
selection in the medulla. If this is a true dogma, there will
be autoimmune responses to the antigens speciﬁcally ex-
pressed in the cortical epithelial cells. However, when other
antigens were targeted into cTEC using the same promoter,
incomplete but signiﬁcant tolerance to the speciﬁc antigens
was observed [27,28]. In the case of a circulating antigen (C5),
all types of thymic APC, including the cTEC, could effect
efﬁcient negative selection in vitro [29]. Finally, the question
of the role of circulating peripheral DC in the induction of
thymic tolerance has also been raised [30] and tested true [31].
Experiments regarding the ability of cTEC to efﬁciently
present antigens have also been controversial. In early
studies, the death of cortical thymocytes upon activation by
antibody or peptides was interpreted as resulting from
antigen presentation by the cortical stromal cells [32,33]. In
addition, a study with puriﬁed thymic APC suggested that
cTEC were able to present antigens to a self-reactive
hybridoma, with an efﬁciency comparable to that of thymic
DC [34]. However, later studies indicated that a cell line with
cTEC properties was inefﬁcient in processing antigens both
in vitro and in vivo [35,36]. In contrast, Volkmann and his
colleagues, using enriched stromal cell preparations from
adult thymus, demonstrated that cTEC are able to present
soluble antigens as efﬁciently as DC or mTEC in reaggregate
cultures. In many, if not all, of the above studies, however,
difﬁculties in interpretation still persist, in particular,
because of a lack of sufﬁcient understanding about the
nature of the deﬁned cTEC subpopulation under study, as
well as the purity of the cells expressing the speciﬁc antigens
that were used in the assays. More recently, Gray and
colleagues reported that well-deﬁned, puriﬁed cTEC, as well
as mTEC, express costimulatory molecules and can stimulate
naive T cells as much as thymic dendritic cells do in vitro [37].
Therefore, we felt it was necessary to re-evaluate the role of
the cTEC subpopulation in central tolerance induction using
a different model system, one perhaps better suited to more
directly answering the question of whether subpopulation of
cTEC can present endogenous antigens and whether this can
lead to deletion of thymocytes.
Previously, in an effort to separate thymic epithelial cell
(TEC) components, we introduced a new marker (Ly110),
designated thymic stromal cotransporter (TSCOT), which is
expressed in a speciﬁc TEC subpopulation. TSCOT is a
putative 12-transmembrane protein, located mainly in the
thymic cortex [38]. TSCOT is not expressed in any other
tissues, as detected by quantitative reverse-transcription PCR
(RT-PCR) [39]. It is also not expressed in thymocytes [38].
TSCOT
þ thymic stromal cells are all MHCII
þ and CDR1
þ/
6C3
þ, well-deﬁned cortical epithelial markers [40], with
observable variations in levels during different developmental
stages [41]. In this study, we introduce a new mouse model
system called TSCOT delta LacZ (TDLacZ) that expresses a b-
galactosidase (b-gal) in the TEC subpopulation. This model
system constitutes a new tool for the study of TEC develop-
ment and function. First, we were able to follow TSCOT-
expressing TEC by b-gal activity assays or antibody staining
and ﬂow cytometry using an anti-TSCOT monoclonal anti-
body (mAb) [41]. LacZ enzymatic activity could also be assayed
for the location of cells with a high degree of sensitivity, in
both sections and the whole organism, and expression could
be assessed in a quantitative manner. Second, because the
protein is generated by an endogenous promoter, this system
is designed to express normal doses of neoself-antigen
relative to other competing cellular proteins. This is in
contrast to some previous systems for the targeting of cortical
expression, in which MHC molecules were displayed at
unusually low levels [19,26]. Third, the absence of the TSCOT
promoter activity in peripheral tissues precludes the involve-
ment of recirculating DCs, which might deliver peripheral
antigens to the thymus, and present them ectopically.
By targeting LacZ protein as a neoantigen within the
T S C O T - e x p r e s s i n gt h y m i ce p i t h e l i u m ,w ew e r ea b l et o
demonstrate that TSCOT
þCDR1
þ TEC alone, without any
help from the mTEC or DC, is able to establish deletional
tolerance in an AIRE-independent manner with a surpris-
ingly high degree of efﬁciency.
Results
A TDLacZ Mouse Model for TEC Subpopulation-Specific
Antigen Expression
We established a new system by knocking-in the LacZ gene
into the TSCOT locus between two BamHI sites (Figure 1A).
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Author Summary
T cells play critical roles in the immune response. While developing
in the thymus (from whence T cells and their precursors,
thymocytes, derive their name), thymocytes are selected for the
ability to recognize harmful antigen (positive selection), while those
that respond to antigens present in their own body are eliminated
(negative selection). Dogma holds that the thymus is divided into
different functional compartments to ensure that these contrasting
selection processes occur efficiently: the cortex is thought to be
responsible for positive selection and the medulla for negative
selection. In this study, we made use of a novel transgenic mouse
(carrying a LacZ marker in a small fraction of cells in the cortex) to
test whether the cortex is really excluded from negative selection.
We were able to show that the introduced LacZ ‘‘antigen’’ present
only in the cortical cells leads them to eliminate any LacZ-reactive T
cells from the immune repertoire and leads to tolerance of the LacZ
‘‘antigen’’ by the body’s immune system. This process is highly
efficient, such that a relatively tiny number of antigen molecules
present in a small fraction of the cells in the thymic cortex can
singularly perform proofreading of all developing thymocytes.LacZ was transcribed in the same message with the 59 portion
of the TSCOT message, and translation of LacZ was
facilitated by incorporating an internal ribosome entry site
(IRES) sequence [42]. The targeting was conﬁrmed by South-
ern blotting (Figure 1B). Northern blotting conﬁrmed that
the LacZ message was in a fusion transcript with the 59
portion of the TSCOT message (Figure 1C).
The TDLacZ mice evidenced no distinguishable abnormal-
ities with regard to thymic structure as the result of the
deletion in TM5-TM12 portion of the TSCOT protein. In
Figure 1E, we show that the similar thymic stromal patterns of
the 2-wk-old homozygote and the wild type. The small
difference in the fraction of stromal cell populations was
within the experimental variations. There was also no
difference detected in the proﬁles between hetero- and
homozygote littermates of the various ages (unpublished
data). The N-terminal portion including transmembrane
spans 1–4 of the protein still remained expressed on the cell
surface, as detected by ﬂow cytometry (unpublished data).
The only apparent difference was for the total thymocyte
yield at 6 wk of age, which was slightly lower in about one-
third of the TDLacZ homozygotes (Figure 1D). However, we
failed to detect any reproducible differences in the proﬁles of
thymocyte population except the individual variation. In
addition, an analysis of 6-mo-old mice also showed no
signiﬁcant differences detected in the recovery of thymocytes
and major proﬁles of CD25, CD44, CD4, and CD8 (unpub-
lished data). When 5CC7 T cell receptor (TCR) Tg mouse was
bred with TDL, no signiﬁcant differences for the thymocyte
populations were found in selecting or nonselecting back-
ground (F. Flomerfelt, unpublished data).
When b-gal activity was assessed in TDLacZ mice at
embryonic day 11 (E11), the time at which thymus organo-
genesis is initiated, LacZ was already expressed in the two
separated thymic rudiments, but it was not expressed in the
wild-type littermates (Figure 1F). This expression was not
detected in any other organs. At E16, when the thymus
harbors mostly developing double-negative (DN) and double-
Figure 1. Targeting LacZ into the TSCOT Locus for Expression in Thymic Epithelium
(A) Schematic presentation ofþ/þ(top), the targeting construct (middle), and the targeted allele (bottom). The restriction sites BclI (BclI) and BamHI (B)
and location of coding regions are shown. The probe (627 bp) used in the Southern blot is shown as a thick line under the targeted allele. PCR typing
primer positions are shown as small arrows.
(B) Southern blot of a BclI digest. The þ/þ allele is 6.5 kb, and the targeted allele is 7.9 kb.
(C) Northern blot for the TSCOT-LacZ fusion message. The probe (TSCOT, LacZ, and GAPDH control) is at the top left.
(D) Total thymocyte yields from D/D, D/þ, and þ/þ. Averages and standard deviations are shown.
(E) Thymic stromal cell analyses of wild type and homozygotes. CD45
  gates of 2-wk-old thymuses are shown for MHCII and UEA-1. The cTEC, mTEC,
and nonTEC gates are indicated.
(F and G) b-gal activity in the developing thymus (E11 and E16, respectively) of fetuses from D/þ and þ/þ littermates. Only the targeted thymus was
stained (within the black circles). Endogenous b-gal activity was detected in the intestines of both mice.
(H) Newborn thymuses from D/D, D/þ, and þ/þ littermates show a gene dose-dependent expression.
doi:10.1371/journal.pbio.0060191.g001
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clear (Figure 1G). In addition, endogenous b-gal activity
appeared in the TDLacZ intestine at E16, as in the wild-type
control (unpublished data). b-gal activity in thymus samples
from newborn TDLacZ pups showed a gene dose dependency
(Figure 1H).
We next located the LacZ-expressing cells in thymic
sections. At the newborn stage, anti-LacZ antibody staining
revealed the expression mostly in the thymic cortex as
expected (Figure 2A). When the thymus had fully matured
(8 wk of age), LacZ activity was also detected in the cortex
(Figure 2B). This is consistent with our previous result that
TSCOT protein and mRNA expression was located in the
cortex [38]. After careful examination, we occasionally found
LacZ staining extends to corticomedullary junction (unpub-
lished data and see later). In an attempt to characterize the
TSCOT-expressing cells in the mature thymus in greater
detail, ﬂow cytometric analysis was conducted using a
TSCOT-speciﬁc mAb. Previously, we group the thymic
stromal cell populations into at least ﬁve different subpopu-
lations [43]. Three main population are cTEC as CDR1
þUEA-
1
 MHCII
hiG8.8
þ,m T E Ca sC D R 1
 UEA-1
þMHCII
hi or
MHCII
medG8.8
þ, as well as nonepithelial population, nonTEC,
CDR1
 UEA-1
 MHCII
 G8.8
 . As shown in Figure 2C, 35.6% of
cTEC (CDR1
þMHCII
hi) population expresses TSCOT, where-
as none of the mTEC or nonTEC population expresses
detectible levels of TSCOT. Although all of the TSCOT-
expressing cells were positive for cortical marker CDR1 [41], a
fraction of TSCOT
þCDR1
þcells were found to express UEA-1
(unpublished data and see Discussion). Finally, we examined
whether TSCOT mRNA was expressed along with FoxN1 and
AIRE mRNAs (Figure 2D). TSCOT and FoxN1 were detectable
only in the MHCII
þCD45
  epithelial compartment. In
contrast, the AIRE message was detectable in both the
epithelial and CD45
þMHCII
þ compartments as expected,
supporting the previous result on the expression in hema-
topoietic stromal cells of the thymus [13–15].
Quantitative Aspects of LacZ Expression in TDLacZ Mouse
Next, in order to measure sensitivity of tolerance induc-
tion, we estimated the average quantity of antigen expressed
in one adult thymus by measuring the b-gal activity of the
LacZ protein in puriﬁed thymic stromal cells. We isolated the
cells from TDLacZ
D/D mice, and stained them with a mAb
against TSCOT (Figure 3A). In this preparation using 28
animals, TSCOT
þ cells (12.3%) corresponded to 1.2 3 10
5
cells. This calculates out to a total of about 4,300 TSCOT
þ
cells per thymus. When this cell preparation was lysed and the
b-gal activity was evaluated (Figure 3B, and unpublished
data), we were able to determine the LacZ concentration
from a standard curve (2310
 11 M of 50-ll reactions). These
numbers corresponded to 5,017 molecules of LacZ protein
per TSCOT
þ cell by the simple mathematical calculation of
concentration3volume3Avogadro number/cell number; 23
10
 11 M 3 50/10
6 3 6.02 3 10
23 molecules in 1.2 3 10
5 cells in
Figure 2. LacZ and TSCOT-Expressing Cells in the Thymus
(A) Analyses of the thymus using an antibody against b-gal in newborns from a TDLacZ mouse heterozygote (D/þ) and a wild type (þ/þ). Hematoxylin
staining is shown on the right.
(B) b-gal activity of the thymus from 8-wk-old homozygous knock-in mouse (D/D)a t1 0 3magnification. Cortical and medullary areas are indicated, and
the boundary between LacZ stained and unstrained areas is artificially marked as a dotted line for better visualization.
(C) Flow cytometric analysis of TSCOT-expressing cells using the markers in total thymic CD45
  stromal cells. The profiles of cortical marker CDR1 and
medullary marker UEA-1. Defined cTEC, mTEC, and nonTEC are gated. Each gated population is shown as TSCOT and UEA-1 levels on the right. Fraction
of TSCOT
þ cells are shown in percentages.
(D) Message expression of TSCOT, FoxN1, AIRE, and GAPDH by sorted thymic compartments according to CD45/MHCII status using RT-PCR (30 cycles).
The cells were isolated either from newborns or 6-wk-old thymuses, and the cell surface markers used for sorting are shown on top.
doi:10.1371/journal.pbio.0060191.g002
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number was 6,825 molecules per cell.
Can Antigen Expressed in TSCOT
þ TEC Elicit Self-
Tolerance?
TDLacZ and wild-type animals were immunized with
recombinant LacZ protein and examined for a LacZ-speciﬁc
polyclonal CD4
þ T cell response. As shown in Figure 4A, a
concentration-dependent LacZ-induced proliferative re-
sponse was detected in puriﬁed CD4
þ lymph node T cells
from wild-type B6 animals, whereas T cells from TDLacZ
mice clearly showed no response to LacZ. Both the hetero-
zygous and homozygous animals showed a large reduction in
proliferation (Figure 4B). LacZ-speciﬁc antibody responses
were then evaluated by ELISA (Figure 4C). When whole LacZ
protein was administered in CFA, wild-type mice produced
both IgG1 and IgG2b isotypes speciﬁc for LacZ. In contrast,
heterozygous and homozygous TDLacZ mice did not produce
such antibodies (Figure 4C, top). In order to assess the
possibility that this represented tolerance at the B cell level,
we administered a GST-tagged loop portion of TSCOT (GST-
Loop) in CFA and screened for speciﬁc antibody responses
with a His-tagged loop protein (His-Loop) in an ELISA. In
this case, with help provided by T cells speciﬁc for GST, both
the heterozygous and homozygous TDLacZ mice made as
much anti-loop IgG1 and IgG2b antibodies as the wild-type
mice (Figure 4C, bottom). These results clearly show that the
presence of LacZ expression in the subpopulation of TSCOT
þ
TEC was sufﬁcient for the tolerization of LacZ-speciﬁc CD4
þ
T cells, and this tolerance is not due to the absence of whole
TSCOT molecules in the animal.
Molecules Involved in TSCOT
þ TEC-Mediated Tolerance
Because AIRE is known to play a key role in the establish-
ment of tolerance to antigens promiscuously/ectopically
expressed in small amounts by mTEC [44–46], we investigated
the possible role of AIRE in TSCOT
þ TEC with regard to the
induction of tolerance. We crossed the TDLacZ mouse with
an AIRE-deﬁcient mouse, and conducted the same prolifer-
ation assay for an anti-LacZ CD4
þ T cell response to the LacZ
protein. As shown in Figure 5, the AIRE-deﬁcient mice
displayed slightly enhanced anti-LacZ responses compared to
the wild type, possibly due to the introduced cross-reactivity
or autoreactivity. When one copy of LacZ was expressed by
breeding the AIRE knock-out (KO) to the TDLacZ mouse, the
anti-LacZ-speciﬁc proliferative response was clearly reduced.
In the speciﬁc responses to 1 lg of antigen, the degrees of
responses contributed by AIRE were similar (difference
between wild type and AIRE KO vs. that between TDLacZ
to TDLacZ AIRE KO). These results strongly suggest the
presence of another pathway that AIRE does not play a major
role in the induction of tolerance to an antigen expressed in
TSCOT
þ TEC.
We further assessed the presence or absence of selected
costimulatory and adhesion molecules in the TSCOT-ex-
pressing cells. Although there has been reports that cortical
epithelium does not express costimulatory molecule by
Figure 3. Estimation of the Number of LacZ Molecules Expressed in the
TSCOT-Expressing Cells
(A) Flow cytometric analysis of the percentage of TSCOT-expressing cells
in the thymus preparation.
(B) Standard curve of b-gal enzyme activity using purified LacZ protein.
The purified LacZ enzyme from the commercial source was measured by
the weight, and the stock enzyme solution was diluted serially to
generate the curve. The open triangle indicates the measured value for a
protein extract generated from 30 TDLacZ homozygous (D/D) thymuses.
doi:10.1371/journal.pbio.0060191.g003
Figure 4. CD4
þ Tolerance to LacZ in the TDLacZ Mouse
(A) CD4
þ T cells of mice immunized with 0, 0.5, 5, or 50 lg of LacZ, were
stimulated with 0, 1, or 10 lg/ml of LacZ. The responses of LacZ
immunized mice in solid lines with open symbols, the adjuvant
immunized mice in dotted lines with closed symbols. Rectangles indicate
þ/þ, and ovals D/D.
(B) The T cells response of þ/þ (rectangles), D/þ (triangles), and D/D
(ovals) immunization with (solid lines and closed symbols) or without
(dotted lines and open symbols) 25 lg of LacZ. There were no significant
differences in the recovery of cell numbers from the immunized mice of
any genotypes.
(C) Antibody isotype profiles ofþ/þ,þ/D, and D/D mice immunized with
LacZ (upper panels) or the GST-TSCOT-Loop (lower panels). The OD
reading of individual serum is shown as a single symbol. Open symbols
are for preimmune serum, and filled symbols are for immunized serum.
IgM (M), IgG1 (G1) IgG2a (G2a), IgG2b (G2b), IgG3 (G3), and IgA (A) levels
are shown.
doi:10.1371/journal.pbio.0060191.g004
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conclusion may be false based on our observation of disparity
between histology and ﬂow cytometry [47]. As shown in
Figure 6A–6C, ﬂow cytometry revealed that TSCOT
þ cells are
all positive for MHCII, CD40, and CD54 expression. In more
detailed analysis, the relative CD40 level of TSCOT
þ cells was
similar to that of some CD45
þ cells (presumably dendritic
cells), and higher than TSCOT
  cells that contain TSCOT
 c-
TEC and mTEC populations (Figure 6B, histogram). An
important costimulatory molecule, CD80 was expressed in
some TSCOT
þ cells as shown in Figure 6D (CD45
  gate and
CD45
 MHCII
hi gate where most of the TSCOT
þ cells reside).
In order to compare the relative levels of CD80 between
mTEC and TCSOT
þcells, the multiparameter analyses in ﬂow
cytometry and in confocal microscopy were applied including
LacZ staining with the stromal cells prepared from TDLacZ
thymus. As seen in (Figures 6E and 6F, and S1). In both
analyses, mean ﬂuorescence intensity (MFI) of the relative
levels of CD80 was higher in TSCOT
þcTEC (CDR1
þLacZ
þ)
than in other cells mTEC (UEA-1
þCDR1
 ) and TSCOT
 cTEC
(CDR1
þLacZ
 ). CD86 was not detected under our conditions,
possibly due to the trypsin-sensitive nature of this marker
(unpublished data). These results clearly suggest that TSCOT
þ
cells can function as efﬁcient APC.
Complete Deletion of Monoclonal TCR Transgenic
Thymocytes Specific for LacZ at the DN Stage in the
Presence of TDLacZ Epithelium
To determine the speciﬁc mechanism for the observed
tolerance, we utilized a monospeciﬁc TCR Tg mouse, BgII (D.
Palmer, Marc R. Theoret, and N. Restifo, unpublished data;
see Materials and Methods) that carries an anti-LacZ TCR
transgene from a CD4
þ LacZ-speciﬁc T cell clone [48]. This
line was crossed with Rag1
 /  to establish a monospeciﬁc
TCR-bearing T cell population. When the BgII
Tg/Tg Rag1
 / 
m o u s ew a sc r o s s e dw i t ht h eT D L a c Z
D/D Rag1
 /  mouse
heterozygote for TCR Tg and TDLacZ, only CD4
  CD8
  DN
cells were detected in the smaller thymus (Figure 7). The total
number of thymocytes recovered was approximately 17.5% of
what was recovered from a TCR Tg mouse. Most of the cells
were arrested at the CD25
hi CD44
  (DN3) stage, similar to
what was observed in a Rag1
 /  mouse (Figure 7B). However,
massive cell death in the DN as well as CD4 and/or CD8 cells
was found only in the BgII
Tgþ TDLacZ
D/þ mouse (Figure 7C).
By contrast, in the BgII Tg alone, the fraction of CD44
 
CD25
  (DN4) cells had the highest DN subpopulation (Figure
7B). Thus, in the presence of LacZ, the TCR Tg thymocytes
appeared to be substantially deleted at the post-DN3 stage as
soon as they expressed their TCR at the cell surface (see
Figures S2 and S3 for the expression of TCR gene and protein
on the surface).
The pattern of thymic stromal cells (gated on CD45
  cells)
observed in the BgII
Tg/þ TDLacZ
D/þ Rag1
 /  mice was also
similar to that of a Rag1
 / mouse (Figure 7D). UEA1
þmTECs,
which are prominent in the adult wild-type thymus, were
barely detected, and thus the proportion of CDR1
þcTECs was
greatly elevated. Therefore, BgII
Tg/þ TDLacZ
D/þ Rag1
 /  mice
do not harbor fully developed mTECs, yet they remain able to
efﬁciently delete developing thymocytes.
Cross-Presentation by DC or mTEC Is Not Involved in
CDR1
þcTEC-Mediated Deletion
In order to exclude the possibility of cross-presentation by
mTEC and DC in the induction of tolerance, we employed a
clean reaggregate thymic organ culture system (RTOC)
[49,50] using UEA-1– and CD45-depleted thymic stroma
reconstituted with puriﬁed anti-LacZ TCR transgenic thymo-
cytes. The stromal cells were prepared from a E14.5 fetal
thymic organ culture, in the presence of 2-dGuo, which
depletes DC, and the population was further depleted of
CD45
þ and UEA-1
þ cells by magnetic bead separation. Using
such cells isolated from wild-type or TDLacZ
þ/D thymus
samples, anti-LacZ TCR-bearing DN and DP cells (1:10 ratio,
similar to that of a normal thymus) from adult BgII
Tg/Tg
animals were reaggregated with them and cultured for 5–6 d.
As shown in Figure 7, the recovery of the thymocytes from the
RTOC with TDLacZ cTECs was between 5%–20% of that
achieved with the wild-type stroma. In addition, these
cultures did not contain a signiﬁcant number of CD4
single-positive (SP) cells (Figure 8A). When the DN and DP
transgenic thymocytes were separately reaggregated with
TDLacZ cTEC (Figure 8B), both subsets showed reduced cell
numbers after culture, indicating that LacZ expression could
also deplete the LacZ-responding DP cells in the RTOC.
Although these results argue against the idea of impaired
differentiation from the DN to the DP stage, they suggest that
developing thymocytes are deleted once they react with
antigens presented in thymic cortical epithelium.
Discussion
In this report, we have examined the induction of tolerance
to a TSCOT
þ TEC subset-speciﬁc antigen. Our results
demonstrate that a small amount of antigen (a few thou-
sand/cell), present in a small number of TEC subset (4,000
cells/thymus), functions as a highly efﬁcient tolerogen in
midst of diverse repertoire. In addition, cortical marker
CDR1
þ TEC delete TCR
þ Tg thymocytes without cross-
presentation by either DC or mTEC. This type of tolerance
was established, at least, partially in an AIRE-independent
manner.
Figure 5. AIRE Is Not Necessary for Tolerance to Antigens Expressed by
TSCOT
þ TECs
Proliferation assays in response to b-gal for lymph node CD4
þ T cells
from LacZ-immunized (10 lg) wild-type (rectangles), TDLacZ (ovals), or
AIRE-deficient (triangles), or from AIRE-deficient 3 TDLacZ (inverted
triangles) mice. The responses of the LacZ-immunized mice (þAg) are
shown as solid lines with closed symbols, while those of the adjuvant-
only immunized mice ( Ag) are shown as dotted lines with open
symbols.
doi:10.1371/journal.pbio.0060191.g005
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þCDR1
þMHCII
hi Compartment in
the Thymic Microenvironment
From the histological analyses, the thymic microenviron-
ment is already known to be complex in nature, and to
change during development [41,51–53]. In addition, histo-
logical analyses alone do not constitute a suitable method for
delineating expression proﬁles for different compartments,
because of the poor cortical staining [43]. Using a combina-
tion of ﬂow cytometry with compartment-speciﬁc markers
[43] and LacZ reporter staining, cortical expression of the
TSCOT locus was conﬁrmed at the newborn stage (Figure 2A
and [37,41,51–53]). In the mature thymus, b-gal activity was
also principally found in the cortex (Figure 2B), and TSCOT
surface expression was exclusively detected in CDR1
þ TEC
populations, not in conventional mTEC or nonepithelial cells
(Figure 2C). However, there are cases in which LacZ activity
staining extends to the corticomedullary junction of mature
TDLacZ thymus and TSCOT marker also stains uncharac-
terized minor population of cells (unpublished data). A part
of these minor populations could be developing transitional
TEC, but this possibility requires further detailed study with
an improved technology that can handle an extremely small
Figure 6. Costimulatory Molecules and Other Surface Marker Profiling of TSCOT-Expressing Cells
(A) MHCII profiles of TSCOT
þ cells (solid line) and TSCOT
  cells (dotted line).
(B) CD40 profile of CD45
  gate on the left, CD40. Histograms of TSCOT
þ, TSCOT
 (mTECþcTEC), and CD45
þ are indicated on the right. Background
histogram of live gate is shown but not indicated.
(C) CD54 profile of CD45
  gate.
(D) CD80 profile of CD45
  gate and MHCII
hi gate.
(E) Histogram of CD80 levels in mTEC (UEA-1
þCDR1
 ), TSCOT
þcTEC(CDR1
þLacZ
þ), TSCOT
 cTEC (CDR1
þLacZ
 ). Specific CD80 stain (solid line) and
background (dotted line) of the same gates are shown. Percentage of positive cells in each gates, MFI of negative and positive gates are indicated.
(F) CD80 expression pattern of selected CDR1 and LacZ stained TDLacZ stromal cells. DIC, CDR1, LacZ, and CD80 staining patterns are shown.
doi:10.1371/journal.pbio.0060191.g006
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þcells are
not part of conventional medullary cells. TSCOT/LacZ was
never detected in the conventional CDR1
 UEA-1
þ mTEC
population (Figure 2C). Thus, we are able to dismiss the
possibility that LacZ is ectopically expressed in the mTEC of
the medulla. Furthermore, TSCOT expression was widely
located in the Rag1
 /  thymus [38], which lacks mature mTEC
(Figure 7C and [54]). In case of BgII mouse on a Rag1
 / 
background, tolerance at the DN stage was very clear when
there was antigen only in the cortical epithelium (Figure 7).
The notion of the exclusion of cortical epithelium in the
induction of tolerance was derived from the transgenic
expression of MHC molecules exclusively in the cortex of the
thymus, using the K14 promoter [25,26]. However, the idea of
an exclusive tolerance niche has been challenged: incomplete,
but signiﬁcant, tolerance was observed when other antigens
were targeted to cTEC using the same promoter [27,28]. In
addition, it has been clearly demonstrated that the K14-
MHCII thymus is in fact autotoleragenic when self-antigens
are presented by its own cortical epithelial cells [22]. Our
current ﬁndings using a speciﬁc TSCOT promoter corrobo-
rate the notion that cTEC participate in the establishment of
CD4 central tolerance in a highly efﬁcient manner. There is
no evidence for autoreactivity to speciﬁc antigens presented
by the TSCOT
þ cells. Instead, we found clear tolerance to
LacZ antigen. Therefore, the TSCOT
þTEC niche of the cTEC
subpopulation is not excluded from the tolerance induction
so that it may avoid autoreactivity against its own cell.
The Mechanism of Tolerance Induction by the TSCOT
þ
TEC Subset
Taking advantage of sensitive enzymatic activity, our
estimate for LacZ under the control of the TSCOT promoter
is about 6,000 (the average of two measurements) molecules
per TSCOT
þ TEC in homozygote thymus (Figure 3). This
number is surprisingly similar to that of the estimation of
mTEC derived from the indirect estimation [55]. However,
one half of this amount in heterozygotes was sufﬁcient to
induce complete CD4 tolerance in the absence of mTEC
(Figures 7 and 8) or DC cross-presentation (Figure 8).
Previous accurate estimates [56] have suggested that recog-
nition of only three to four peptide/MHC complexes by an
immature thymocyte was sufﬁcient to generate a negative
selection event in transgenic mouse. Therefore, it remains a
challenging question as to how such a high efﬁciency is
achieved. The number of cTEC in the adult thymus is far less
than that of mTEC [43]. The total number of TSCOT
þ TEC,
estimated from a large pool of adult thymuses, was only on
the order of several thousand per thymus. In order to screen
all of the developing thymocytes for potential autoreactivity,
the frequency of cell encounters between cTEC presenting
the speciﬁc antigen and thymocytes would have to be
Figure 7. Anti-LacZ–Specific TCR-Bearing Transgenic Thymocytes Are
Deleted at the DN Stage in the Presence of TSCOT-LacZ Expression
(A) CD4 and CD8 thymocyte profiles. The names of each of the four
mouse strains used and their total thymocyte yields are shown above the
plots. The percentages of the single and double staining subsets are
shown in the four quadrants.
(B) CD25 and CD44 profiles of the DN thymocytes with percentages in
the quadrants.
(C) Annexin V staining of all cells stained with CD4, CD8, and PI shown in
FL3 channel. PI
þ cells are at the top, DP and SP cells in the middle, and
DN cells in the bottom.
(D) The UEA-1 and CDR1 profiles of the CD45
 stromal cell compartment
from the four different mouse lines. The genotypes of each mice are
verified for the loci of Rag1, TDL, and TCR a and b chains by PCR
doi:10.1371/journal.pbio.0060191.g007
Figure 8. DC and mTEC Are Not Necessary for the Deletion of Transgenic
Thymocytes
Sorted anti-LacZ TCR thymocytes were reaggregated with UEA-1–
depleted CD45
  stromal cells from dGuo-treated fetal thymuses. (A)
Flow cytometric profiles of reaggregate cultures initiated with 3.8 3 10
5
DNþDP (1:10 ratio) and 5310
5 purified thymic stroma at day 5 (top) or
day 6 (bottom). The sources of stromal cells and thymocytes are
indicated at the top of the graphs. CD4 and CD8 profiles are shown
along with the percentage of cells in each of the compartments.
Typically, cell recoveries of the DN and DP thymocyte mixtures cultured
with TDLacZ heterozygote (þ/D) stroma were 20%–30% of thymocyte
mixtures cultured with wild-type (þ/þ) stroma.
(B) A representative cell recovery when DN and DP cells were cultured
separately with purified stroma from the wild type (þ/þ) versus the
heterozygote (þ/D ) mouse. Underlined numbers indicate the initial
numbers of cells that were input.
doi:10.1371/journal.pbio.0060191.g008
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DP thymocytes remain in the cortex [57,58]. This could be
accomplished in thymic nurse cells in which multiple
thymocytes are found in association with one epithelial cell.
Several earlier papers had come to the conclusion that the
thymic epithelium induced tolerance by the induction of
anergy, rather than deletion [59,60]. In contrast, in our anti-
LacZ TCR Tg 3 TDLacZ model, it is evident that deletion is
the dominant mechanism (Figure 7). Deletion has also been
observed in a number of other TCR transgenic systems
[28,61]. Whether this is a normal physiological process or
death subsequent to developmental arrest following the
premature expression of a transgenic receptor at the DN
stage was questioned [62]. However, DP thymocytes included
in the RTOC were also deleted, arguing that cTEC-induced
tolerance involves the speciﬁc deletion rather than the arrest
at premature developmental stage (Figure 8B).
In the TDLacZ thymus, cortical epithelium expressing a
speciﬁc antigen was able to tolerize quite thoroughly (Figures
7 and 8). This was somewhat surprising if thymic epithelial
cells are poor presenters of antigen as concluded earlier on
the poor expression of costimulatory molecules in cTEC [63].
However, we clearly show that TSCOT
þ cTEC express high
levels of MHCII, CD54, CD40, and CD80. Surface CD40 and
CD80 proteins in particular are expressed at surprising levels
that are even higher than those of mTEC (Figure 6).
According to the RT-PCR result from the puriﬁed cells,
CD40, CD80, and CD86 message levels are slightly higher in
mTEC than cTEC ([37] and unpublished data). Among cTEC,
TSCOT
þ cells are the ones expressing more costimulatory
molecules (Figures 6 and S1). Therefore, molecules on the
TSCOT
þcTEC can provide the environment for the highly
efﬁcient deletional tolerance of TCR bearing early thymo-
cytes Figure S2) through a unique TSCOT
þ cTEC antigen
presentation process. As seen in ﬁgure 7C, massive apoptosis
events in DN TCR transgenic cells in the presence of the LacZ
antigen-bearing cTEC are also consistent with the deletional
tolerance.
In order to determine the molecular mechanism under-
lying the induction of tolerance, we determined whether or
not AIRE was involved. It has been fairly well established that
AIRE is involved in mTEC-mediated tolerance induction by
facilitating the expression of peripheral antigens in normal
and genetically modiﬁed animals [12,64,65]. As a result of the
introduction of one copy of the LacZ gene into AIRE-
deﬁcient animals, the LacZ-speciﬁc CD4 proliferative re-
sponse was signiﬁcantly reduced (Figure 5). Since AIRE
expression was, mostly, assumed to be absent in the normal
CDR1
þ cTEC (except Rag1
 / ), it is not surprising that AIRE
was not directly involved in TSCOT
þ TEC-induced tolerance.
Instead, it may suggest that the AIRE-independent tolerance
pathway exists in the TSCOT
þ TEC. However, there was still
the question of whether tolerance was induced by AIRE-
expressing DC or mTEC, via a cross-presentation. The results
obtained with RTOC using thymocytes from LacZ-speciﬁc
TCR transgenic mice and puriﬁed CD45
 UEA-1
 CDR1
þ cells
from 2-dGuo–treated FTOC (Figure 7) show that neither DC
nor mTEC are necessary for tolerance induction in vitro. The
direct involvement of TSCOT
þ TEC in deletional tolerance
constitutes strong evidence for the capacity of direct antigen
presentation [29,32–36]. More detailed studies will be
required to identify the speciﬁc molecules that are involved
in this type of antigen presentation.
Are Affinity/Avidity Models Sufficient to Explain Central
Tolerance by Cortical Epithelium?
It is generally accepted that negative selection requires
speciﬁc conditions of either high-avidity interaction or
prolonged signaling [20,66,67]. The quantitative aspects
discussed above seem insufﬁcient to explain negative selec-
tion by a simple afﬁnity/avidity model for cTEC. The surface
and cytoplasmic levels of MHCII in cTEC are not appreciably
lower than in mTEC and MHCII molecules exist on cTEC as
aggregates on the surface [43]. Thus, if a self-peptide was
presented at sufﬁciently high concentrations to display
multiple complexes in the same aggregate at any one time,
these MHCII aggregates could potentially generate high-
avidity signaling leading to thymocyte death. If so, then
cortical epithelium could function directly in both negative
and positive selection. In line with this notion, it has been
shown that a single cTEC line can mediate both positive and
negative selection [68]. If the amount of any antigen
produced by a cTEC is low, then under normal conditions
with a random loading mechanism for a diverse set of
endogenous peptides [69], a single MHCII aggregate on the
cTEC surface would likely contain only one peptide/MHC
complex. This would hinder an avidity-based mechanism
from operating as there would be no multimeric presenta-
tion. Although such monomeric presentation might be
adequate for positive selection, it seems that it would be
inadequate for negative selection. This raises the possibility
that other mechanisms might exist for increasing the antigen
density on cTEC. Such a mechanism might involve inter-
cellular antigen transfer [70], in addition to sampling of other
self-antigen pools [8,71]. However, the expression of costi-
mulatory molecules on TSCOT
þ cTECs is consistent with the
idea that the presence of costimulation/second signals may
distinguish negative from positive selection.
Materials and Methods
Mice. All mice were handled according to American Association
for Accreditation of Laboratory Animal Care Regulations.
In order to generate mice carrying an inserted LacZ allele at the
TSCOT locus, a 4.2-kb targeting vector was constructed by cloning
IRES-LacZ with a neo-selectable marker from p1049 [42] between two
BamHI sites in the ﬁrst exon of the TSCOT gene. A Herpes Simplex
Virus thymidine kinase (HSV-TK) expression cassette was positioned
at the 59 end of the construct in order to facilitate negative selection
for homologous recombination. The targeted allele harbors an IRES-
LacZ and PGK-neomycin expression cassette within the ﬁrst exon,
resulting in a small deletion (284 bp) between the two BamHI sites
within exon 1. The mouse 129 embryonic stem cell line (R1) was
electroporated with the construct, and the neomycin-resistant clones
were screened in the laboratory of Dr. Hua Gu (National Institute of
Allergy and Infectious Diseases [NIAID]/ National Institutes of Health
[NIH]). Chimeras were generated by blastocyst injection, and one
founder mouse was backcrossed to C57BL/6Tac.
To study antigen-speciﬁc CD4
þ T cell responses to b-gal, a
transgenic mouse strain on a C57BL/6 background was developed
and named BgII. RNA was isolated from an I-Ab–restricted, b-gal–
speciﬁc CD4þ T cell clone. Total mRNA was isolated using a Qiagen
RNeasy kit, and the a and b TCR were ampliﬁed by 59-Rapid
Ampliﬁcation of cDNA Ends (59-RACE, Life Technologies) using
constant region anti-sense primers a1 (59-GGCTACTT TCAGCAG-
GAGGA-39) and b1 (59-AGGCCTCTGCACTGATGTTC-39), respec-
tively. The 59-RACE products were ampliﬁed with nested TCR a and b
constant region primers a2 (59-GGGAGTCAAAGTCGGTGAAC-39)
and b2 (59-CCACGTGGTCAGGGAAGAAG-39), and cloned into
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PCR primers were designed based upon the method previously
described [72]. The genomic variable domains were TA cloned into
pCR4TOPO (Invitrogen), validated by sequencing, subcloned into
TCR cassette vectors kindly provided by Dr. Diane Mathis (Harvard),
and coinjected into fertilized C57BL/6 embryos (SAIC) yielding TCR
transgenic founder which were then bred.
PCR genotyping.
Tail or ear samples were employed for genotyping, using the red
Extract-N-Amp Tissue PCR kit (Sigma) and primers: for the TSCOT
locus, Neo primer: ACCGCTATCAGGACATAGCGTTGG, 1C12 F1:
TTACTCAAAGTGATGCTGGACTGG, 1C12 B2: CCGAGGG-
TTCCTTGGTACATTC; for the RAG1 locus, Neo primer: ACCGCTA-
TCAGGACATAGCGTTGG, Rag-1 F: TCGTTTCAAGAGT-
GACGGGCAC, Rag-1 B: AATCCTGGCAATGAGGTCTGG; and for
the AIRE locus, forward primer: GTCATGTTGACGGATCCAGGGTA-
GAAAGT, reverse primer: AGACTAGGTGTTCCCTCCCAACCTCAG.
For the anti-LacZ TCR transgenic allele, BG2 Alpha F1: ACAACCCGG-
GATTGGACAG, BG2 Alpha R1: GTATAGCGGCCGCCTCCTAGTG-
CAATGGT, BG2 Beta F1: TATCTCGAGTCCTGCCGTGACCC-
TACTATG; BG2 Beta R1: CAGCCGCGGAACCCAACACAAAAACTA-
TAC.
Flow cytometry. Antibodies used for ﬂow cytometric analysis were
as follows: for stromal cells, FITC-conjugated anti-mouse I-A
b (A
b)
AF6–120.1 (BD Pharmingen), CDR1-PE (prepared by L. Lantz,
NIAID ﬂow cytometric facility), CD45 PE-Texas Red conjugate
(Caltag), biotinylated Ulex europaeus agglutinin-1 (Vector Laborato-
ries), streptavidin-APC (BD Pharmingen), CLVE1 anti-TSCOT mAb
(prepared by Dr. L. Lanz, NIAID), and FITC-conjugated goat anti-
Rat IgM (Jackson Laboratories). For thymocytes, FITC-conjugated
anti-mouse CD4 (L3T4) (GK1.5) (BD Pharmingen), PE-conjugated
anti-mouse CD44 (BD Pharmingen), mouse CD8a PE-Texas Red
conjugate (Caltag), biotin-conjugated anti-mouse CD25 (BD Phar-
mingen), streptavidin-APC (BD Pharmingen), annexinV-FITC
(Clontech), PE-conjugated anti-mouse CD69 (BD Pharmingen),
CD4 PE-Texas Red conjugate (Caltag), biotin anti-mouse abTCR
(H57–597) (BD Pharmingen), FITC-conjugated anti-mouse CD44
(BD Pharmingen), PE-conjugated anti-mouse CD25 (BD Pharmin-
gen), APC-conjugated anti-mouse CD4 (L3T4) (GK1.5) (BD Phar-
mingen), and APC-conjugated anti-mouse CD8a (BD Pharmingen).
For LacZ staining, after treating with 30 mM chloroquine
diphosphate to block endogenous b-gal activity for 30 min at 37
8C, 33 lM ImaGene Red C12RG substrate (Molecular Probes,
ImaGene Red C12RG lacZ Gene Expression Kit I-2906) was used
in FACS buffer for 20 min at 4 8C.
b-galactosidase activity and antibody staining. Either whole
embryos or isolated thymuses were washed in PBS and ﬁxed in 1%
paraformaldehyde, 0.2% glutaraldehyde, 0.02% NP-40, 1 mM MgCl2
in PBS for 1 or 2 h on ice. Staining was conducted using X-gal
solution with 100 mM D-galactose in 2 mM MgCl2, 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide overnight at 37 8C [42].
For the sections, the thymuses were embedded in Tissue Freezing
Medium (Triangle Biomedical Sciences). The 4-lm sections were
ﬁxed for 2 min in 1% formaldehyde, 0.2% glutaraldehyde, 0.02% NP-
40 1 mM NaCl, then incubated with X-gal solution (1 part X-gal 40
mg/ml in dimethyl formamide, in 40 parts 2 mM MgCl2,5m M
potassium ferricyanide, 5 mM potassium ferrocyanide in PBS) at 37
8C for 48 h. For antibody staining, the parafﬁn sections were stained
with DAKO CSA reagent. For the LacZ Lysis assays, thymic cells from
30 TDLacZ mice or control C57BL/6 mice were partially puriﬁed via
MACS CD45-bead sorting (Miltenyi Biotech). The cell pellets were
lysed using Reporter Lysis Buffer from the b-Galactosidase Enzyme
Assay System with Reporter Lysis Buffer (Promega). After lysis and
centrifugation, the Assay Buffer was added to each supernatant as
well as to enzyme aliquots for a standard curve, and then incubated
for 30 min at 37 8C. Absorbance was then measured at a wavelength of
405 nm.
Cytospin and confocal microscopy. Isolated TEC (about 10
5) were
washed in cold FACS buffer (PBS þ 1% BSA), subsequently stained
on ice with 2.4G2, APC-conjugated anti-CDR1, biotinylated anti-
CD80 (B7–1, Armenian hamster IgG2j) followed by streptabidin-
Alexa568 (Molecular Probes). For the detection of LacZ-expressing
cells, ImaGene Green C12FDG lacZ Gene Expression kit (Molecular
Probes) was used. Stained samples were placed on the slides by
cytospin at 1,200 rpm for 2 min. Images were collected on LSM 510
META (Zeiss), and analyzed with LSM Image Examiner (Zeiss) and
Photoshop.
CD4
þT cell in vitro proliferation assay. Three mice per group were
immunized with the afﬁnity-puriﬁed, LPS-removed recombinant
proteins in Complete Freund’s Adjuvant in one footpad and the
base of the tail. Ten days after immunization, the mice were sacriﬁced
and the inguinal, mesenteric, and para-aortic lymph nodes were
collected and crushed in Iscov’s Modiﬁed Dulbecco’s Medium. The
CD4
þ cells were collected from MACS columns using anti-CD4
antibody (GK1.5) (purity of the cells were usually over 95%) and
incubated at 37 8C with irradiated whole spleen cells and 0, 1, 10, or
100 lg of LacZ protein (in triplicate). The cells were pulsed with
3H-
thymidine for the ﬁnal 24 h of a 72-h incubation. The cells were
harvested with a Brandel 96-well harvester, and thymidine incorpo-
ration into DNA was measured with a Wallac Trilux 1450 b-
scintillation counter.
Detection of antibodies to LacZ by ELISA. The mice were
immunized intraperitoneally with either LacZ or puriﬁed recombi-
nant GST-TSCOT-Loop protein in CFA, three times every other
week. The mice were bled 3 d after the last injection, and the sera
were incubated on His-LacZ protein or His-Loop–coated (5 lg/well)
ELISA plates. The bound anti-LacZ Ab was detected with anti-mouse
immunoglobulin isotype-speciﬁc antibodies conjugated with HRP
and assayed with ABTS solution (Southern Biotechnology Associates)
by following the manufacturer’s description. Optical density (OD) was
measured at 405 nm.
Reaggregate thymic organ culture (Anderson and Jenkinson
Protocol). The thymic stromal cells were prepared by treating E14.5
fetal thymus samples with 2-dGuo for a week. UEA-1
 and CD45
 cells
were then puriﬁed using biotinylated reagents and streptavidin-
MACS beads. Thymocytes from anti-LacZ TCR transgenic mice were
sorted for DP and DN cells and reaggregated with the stromal cells
using protocols developed by Anderson and Jenkinson at the
University of Birmingham, United Kingdom [49]. Recovered cells
were counted and then analyzed by ﬂow cytometry after 4–6 d of
culture.
Supporting Information
Figure S1. Quantitative CD80 Analysis of mTEC, TSCOT
þ cTEC, and
TSCOT
  cTEC
The analysis was performed using confocal microscopic data. Levels
of CD80 were measured using the sum of intensities in the cell area
over the background (TINA2.09f, Pusan National University). Percent
of maximum (max) was calculat e dw i t ha na v e r a g eo ft h r e e
CDR1
þLacZ
þ cells. Bars and dots represent the average and each
values, respectively. Asterisk indicates area from the adjacent cell was
excluded for the measurement.
Found at doi:10.1371/journal.pbio.0060191.sg001 (2.09 MB TIF).
Figure S2. Genotyping of TCR Transgenic Mouse
Genotyping was done as described in Materials and Methods. Copy of
the relevant page for the mouse information and the genotyping
results are shown.
Found at doi:10.1371/journal.pbio.0060191.sg002 (1.60 MB TIF).
Figure S3. Expression of Transgenic TCR during Thymocyte
Development
TCR levels were detected with anti-TCRb chain antibody (H57) in
combination with other antibodies in ﬂow cytometry. CD4 and CD8
proﬁles, and DN, DP, and CD4 gates are shown in the top left panel;
TCR levels of respective gates are shown on the upper right. DN gated
CD44 and CD25 proﬁles, and DN1, DN2þ3, and DN4 gates are shown
on the lower left. TCR levels of respective DN gates are shown on the
lower right. Solid lines in the histogram show the TCR levels of each
gate in the CD4 TCR transgenic mouse; dotted lines show those of the
same gated in the wild-type B6 mice.
Found at doi:10.1371/journal.pbio.0060191.sg003 (3.35 MB TIF).
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